MedPath

Fast-track thyroidectomy and I-131 radioiodine ablation therapy in patients with differentiated thyroid cancer.

Withdrawn
Conditions
10014713
10043739
Thyroid cancer
Registration Number
NL-OMON38352
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

1. Patients with papillary thyroid cancer, stage T1-3N0-1M0
2. Patient planned for total thyroidectomy

Exclusion Criteria

1. T4 or M1 tumours
2. Patients with differentiated thyroid cancer other than papillary or follicular variant of papillary thyroid cancer (= follicular thyroid cancer, Hurthle cell carcinoma or tall cell carcinoma)
3. Incapacitated patients
4. Pregnant patients
5. Patients with detectable Tg antibodies at 1 year follow-up will be excluded for analysis
6. Contrast enhanced CT performed < 4 months prior to inclusion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Reduction of sick-leave time</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes will be quality of life, societal costs and efficacy of the<br /><br>treatment.</p><br>
© Copyright 2025. All Rights Reserved by MedPath